<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We previously have reported on an experimental athymic mouse model in which regression of human Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is induced by either coinjection with or intratumor inoculation of Epstein-Barr virus (EBV)-immortalized human B cells </plain></SENT>
<SENT sid="1" pm="."><plain>In the current study, we were interested in determining whether the powerful antitumor effects of EBV-immortalized B cells could be effective against a variety of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> grown in athymic mice, including <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002861'>malignant melanoma</z:hpo>, <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo>, <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>, <z:mp ids='MP_0008714'>lung carcinoma</z:mp>, <z:mp ids='MP_0009314'>colon adenocarcinoma</z:mp>, <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo>, Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> and breast <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We report here the results of experiments in <z:mp ids='MP_0003815'>nude</z:mp> mice that demonstrated the potent antitumor effect of EBV-immortalized B cells against human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> derived from a variety of different tissues </plain></SENT>
</text></document>